After the approval of the United States Food and Drug Administration (USFDA), the company has launched Amlodipine Olmesartan Medoxomil tablets in the US market through its arm Ajanta Pharma USA Inc," the company said in a BSE filing on Wednesday.
The company's product is a generic version of Daiichi Sankyo Inc's Azor tablets, it added.
The product has been launched in four strengths 5mg20mg, 5mg40mg, 10mg20mg and 10mg40mg, Ajanta Pharma said.
"Amlodipine Olmesartan Medoxomil tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market," it added.
Shares of the company today closed 1.84 per cent down at Rs 1,960.35 apiece on BSE.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.